A Dark Vector Cognition product

Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET AND BUSINESS RISKS

9K characters. Original on sec.gov · Markdown

Item 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET AND BUSINESS RISKS

Foreign Currency Market Risk

Our reporting currency is the U.S. dollar, although the financial statements of our non-U.S. subsidiaries are maintained in their respective local currencies. We transact business in various foreign currencies, including a number of major European currencies as well as the Australian dollar. We have significant foreign currency exposure through both our Australian and Singapore manufacturing activities and international sales operations. We have established a foreign currency hedging program using purchased currency options and forward contracts to hedge foreign-currency-denominated financial assets, liabilities and manufacturing cash flows. The goal of this hedging program is to economically manage the financial impact of foreign currency exposures predominantly denominated in euros, Australian dollars and Singapore dollars. Under this program, increases or decreases in our foreign-currency-denominated financial assets, liabilities, and firm commitments are partially offset by gains and losses on the hedging instruments. We do not enter into financial instruments for trading or speculative purposes. The foreign currency derivatives portfolio is recorded in the consolidated balance sheets at fair value and included in Other assets current, Other assets non-current, Accrued expenses and Other liabilities non-current. All movements in the fair value of the foreign currency derivatives are recorded within Other income, net, on our consolidated statements of income.

The table below provides information (in U.S. dollars) on our significant foreign-currency-denominated financial assets by legal entity functional currency as of June 30, 2022 (in thousands):

U.S. Dollar (USD)Euro (EUR)Canadian Dollar (CAD)Chinese Yuan (CNY)
AUD Functional:
Net Assets/(Liabilities)105,745(50,884)—16,913
Foreign Currency Hedges(60,000)31,397—(11,941)
Net Total45,745(19,487)—4,972
USD Functional:
Net Assets/(Liabilities)——15,619—
Foreign Currency Hedges——(19,423)—
Net Total——(3,804)—
SGD Functional:
Net Assets/(Liabilities)373,19814,852—882
Foreign Currency Hedges(385,000)———
Net Total(11,802)14,852—882

The table below provides information about our foreign currency derivative financial instruments and presents the information in U.S. dollar equivalents. The table summarizes information on instruments and transactions that are sensitive to foreign currency exchange rates, including foreign currency call options, collars and forward contracts held at June 30, 2022. The table presents the notional amounts and weighted average exchange rates by contractual maturity dates for our

-59-

Table of Contents

PART IIItem 7A
RESMED INC. AND SUBSIDIARIES Quantitative and Qualitative Disclosures About Market and Business Risks

foreign currency derivative financial instruments. These notional amounts generally are used to calculate payments to be exchanged under the options contracts (in thousands, except exchange rates):

Fair Value Assets / (Liabilities)
Foreign Exchange ContractsYear 1Year 2TotalJune 30, 2022June 30, 2021
USD/AUD
Contract amount60,000—60,000(190)(652)
Ave. contractual exchange rateUSD 1 = AUD 0.6928USD 1 = AUD 0.6928
AUD/EUR
Contract amount88,95915,699104,658(413)1,172
Ave. contractual exchange rateAUD 1 = EUR 0.6867AUD 1 = EUR 0.6800AUD 1 = EUR 0.6857
SGD/EUR
Contract amount20,931—20,93171(88)
Ave. contractual exchange rateSGD 1 = Euro 0.7117—SGD 1 = Euro 0.7117
SGD/USD
Contract amount385,000—385,000(1,172)(177)
Ave. contractual exchange rateSGD 1 = USD 0.7216SGD 1 = USD 0.7216
AUD/CNY
Contract amount11,941—11,941(37)(130)
Ave. contractual exchange rateAUD 1 = CNY 4.6449AUD 1 = CNY 4.6449
EUR/USD
Contract amount————169
Ave. contractual exchange rateUSD 1 = EURUSD 1 = EUR
USD/CAD
Contract amount19,423—19,423(46)(44)
Ave. contractual exchange rateUSD 1 = CAD 1.2902USD 1 = CAD 1.2902

Interest Rate Risk

We are exposed to risk associated with changes in interest rates affecting the return on our cash and cash equivalents and debt. At June 30, 2022, we held cash and cash equivalents of $273.7 million principally comprising of bank term deposits and at-call accounts and are invested at both short-term fixed interest rates and variable interest rates. At June 30, 2022, there was $280.0 million outstanding under the revolving credit and term loan facilities, which were subject to variable interest rates. A hypothetical 10% change in interest rates during the year ended June 30, 2022, would not have had a material impact on pretax income. We have no interest rate hedging agreements. On July 10, 2019, we entered into the Note Purchase Agreement with the purchasers to that agreement, in connection with the issuance and sale of $250.0 million principal amount of our 3.24% senior notes due July 10, 2026, and $250.0 million principal amount of our 3.45% senior notes due July 10, 2029. The interest rate on these notes is fixed and not subject to fluctuation.

Inflation

Inflationary factors such as increases in the cost of our products, freight, overhead costs or wage rates may adversely affect our operating results. Sustained inflationary pressures in the future may have an adverse effect on our ability to maintain current levels of gross margin and operating expenses as a percentage of net revenue if we are unable to offset such higher costs through price increases.

-60-

Table of Contents

PART IIItem 8
RESMED INC. AND SUBSIDIARIES

Previous: Item 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS · Next: Item 8. CONSOLIDATED FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA